摘要
疼痛已成为一大社会和临床问题,由于目前的治疗没有提供足够缓解疼痛的方法。疼痛受体的可塑性与感觉神经元的敏感性和非神经细胞释放的可溶性介质一起阻碍了我们掌控疼痛发展的空间和时间尺度、神经元的反应和疾病的进展。在病理条件下, ATP是激活P2X受体最有力的介质之一,P2X受体类似于ATP检测器,例如神经元P2X3受体亚型和P2X4和P2X7受体上表达非神经元细胞。仔细分析感觉神经元和在辅助细胞中发生的分子机制,为设计适当组织-细胞- 靶向方法来治疗慢性疼痛提供了可能。
关键词: 三磷酸腺苷,三磷酸腺苷,痛觉过敏,伤害性感受,嘌呤信令。
Current Medicinal Chemistry
Title:P2X Receptors, Sensory Neurons and Pain
Volume: 22 Issue: 7
Author(s): Tanja Bele and Elsa Fabbretti
Affiliation:
关键词: 三磷酸腺苷,三磷酸腺苷,痛觉过敏,伤害性感受,嘌呤信令。
摘要: Pain represents a very large social and clinical problem since the current treatment provides insufficient pain relief. Plasticity of pain receptors together with sensitisation of sensory neurons, and the role of soluble mediators released from non-neuronal cells render difficult to understand the spatial and temporal scale of pain development, neuronal responses and disease progression. In pathological conditions, ATP is one of the most powerful mediators that activates P2X receptors that behave as sensitive ATP-detectors, such as neuronal P2X3 receptor subtypes and P2X4 and P2X7 receptors expressed on non-neuronal cells. Dissecting the molecular mechanisms occurring in sensory neurons and in accessory cells allows to design appropriate tissue- and cell- targeted approaches to treat chronic pain.
Export Options
About this article
Cite this article as:
Tanja Bele and Elsa Fabbretti , P2X Receptors, Sensory Neurons and Pain, Current Medicinal Chemistry 2015; 22 (7) . https://dx.doi.org/10.2174/0929867321666141011195351
DOI https://dx.doi.org/10.2174/0929867321666141011195351 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Can Dietary Antioxidants Reduce the Incidence of Brain Tumors?
Current Drug Metabolism Next Generation Tyrosine Kinase Inhibitor (TKI): Afatinib
Recent Patents on Anti-Cancer Drug Discovery OIP5-AS1: A Fascinating Long Noncoding RNA in Carcinoma
Current Pharmaceutical Design The Emerging Pharmacology of TRPM8 Channels: Hidden Therapeutic Potential Underneath a Cold Surface
Current Pharmaceutical Biotechnology Expression of Fucosyltransferases Contributes to Melanoma Invasive Phenotype
Medicinal Chemistry Cancer Microbiome; Opportunities and Challenges
Endocrine, Metabolic & Immune Disorders - Drug Targets Medicinal Plants and Cancer Chemoprevention
Current Drug Metabolism Specific Hemosiderin Deposition in Spleen Induced by a Low Dose of Cisplatin: Altered Iron Metabolism and Its Implication as an Acute Hemosiderin Formation Model
Current Drug Metabolism Cancer Stem Cells: A New Paradigm for Understanding Tumor Growth and Progression and Drug Resistance
Current Medicinal Chemistry Recent Progress on Anti-Liver Fibrosis Candidates in Patents of Herbal Medicinal Products
Recent Patents on Food, Nutrition & Agriculture Melatonin, a Potential Therapeutic Agent for Smooth Muscle-Related Pathological Conditions and Aging
Current Medicinal Chemistry Genetic Variations in Telomere Maintenance, with Implications on Tissue Renewal Capacity and Chronic Disease Pathologies
Current Pharmacogenomics and Personalized Medicine Vitamin D Metabolites and/or Analogs: Which D for Which Patient?
Current Vascular Pharmacology Alternative Splicing: A Promising Target for Pharmaceutical Inhibition of Pathological Angiogenesis?
Current Pharmaceutical Design Targeting Malignancies with Disulfiram (Antabuse): Multidrug Resistance, Angiogenesis, and Proteasome
Current Cancer Drug Targets Chemical and Biochemical Basis of Cell-Bone Matrix Interaction in Health and Disease
Current Chemical Biology Potential Role of <i>In Vitro-In Vivo</i> Correlations (IVIVC) for the Development of Plant-Derived Anticancer Drugs
Current Drug Targets Current Trends and Future Directions of Fluoroquinolones
Current Medicinal Chemistry Natural Products as Anticancer Agents
Current Drug Targets Plant Extracts and Isolated Compounds Reduce Parameters of Oxidative Stress Induced by Heavy Metals: An up-to-Date Review on Animal Studies
Current Pharmaceutical Design